As we move into a post-pandemic health care world, it’s more essential than ever to share information, ideas, and insights that fit the moment. At AHIP’s State Issues Retreat, connect with leaders from coast to coast who are working to make health care better, equitable, and affordable for all Americans.
You’ll engage in-depth, real-time conversations with state lawmakers, health insurance provider executives, and health care influencers on the topics that matter most for your state and the communities you serve.
Attendance is limited to AHIP health insurance provider members, AHIP retained counsels, and state trade association executives.
The on-the-ground work health plans, state trade associations and AHIP retained counsel do in state capitols each and every day is incredibly important to ensuring all Americans have access to affordable, high-quality, and equitable health care. This is mission critical. Hear from AHIP leadership on how state advocacy is impacting the industry.
ERISA plays an important role in employers’ ability to design and administer their own health plans and employ third party administrators to assist in such functions. The SCOTUS decision in Rutledge was narrow and does not authorize expansive state authority. Participate in a moderated discussion about the importance of ERISA and the impact of beyond Rutledge state efforts to regulate self-insured employer plans.
Federal and state policymakers are increasingly looking to alternative coverage legislative options as viable solutions to coverage and health care price concerns. This panel will explore the alternative coverage legislation that was contemplated or passed in a handful of states.
As the price of prescription drugs continue to rise, policymakers are actively seeking relief for Americans needing pharmacy care. Rather than reducing their prices, drug manufacturers are actively advancing policy proposals that will protect them against transparency and accountability. This panel will discuss the industry’s public policy work to ensure all Americans have access to affordable drugs.
This panel will discuss what to expect next in Medicaid programs in states across the country and the efforts underway to continue to strengthen mature programs, integrate new populations and services and expanding access through public private partnerships.
As the COVID pandemic put a spotlight on the crucial role of telemedicine, this session will examine upcoming clinical and operational innovations in this growing facet of health care. Speakers in this session will discuss what is next in quality initiatives, network expansion, and integrated care.
While states have been debating surprise billing for over a decade, with the new federal law, how do we navigate the differences between state and federal law, while keeping the consumer out of the middle. Hear from a panel of experts as they provide insight on questions we still have leading into the into a fast approaching 2022 deadline.
The No Surprises Act, federal transparency rules, and many other recent federal developments provide new important health insurance provider requirements. This panel will review these important developments to equip states in educating policy leaders on these provisions.
In 2021, state legislatures introduced dozens of dental bills, many of which would unnecessarily increase costs for dental plans, leading to higher premiums and restricted access to care. Gain insight into the biggest threats, challenges and opportunities facing dental plans across the country and learn how we can be ready for what’s coming next in 2022.
The COVID-19 global pandemic cast an important spotlight on the intersection of clinical care and public health. A deeper understanding of this intersection is critical. There are many important lessons & best practices to be learned and utilized to frame future effective collaboration and integration to improve individual and population health. This session will explore these lessons – both best practices and challenges and offer compelling reasons why this work is important to future advocacy efforts.
Health care affordability is a top priority for health insurance providers. Participate in a moderated discussion about the industry effort to advance consequential affordability policy reforms.
Prescription drugs are an important part of the health care system and patients rely on medicines to keep them healthy. Unfortunately, prices for prescription drugs have soared in recent years. To improve access to prescription drugs and to make new treatments more affordable, health care stakeholders should promote policies that preserve needed innovation and competition, while also promoting greater transparency to improve the value of prescription drugs for patients. Hear about state efforts to do just that – drive transparency and accountability.
As we continue to focus our attention on ensuring every American has access to affordable, high-quality, equitable care, we must address and combat the inequities that stem from structural racism, historical disenfranchisement, and discrimination of marginalized groups including racial and ethnic minorities, low-income populations, and members of the LGBTQ+ community. AHIP, along with health insurance providers, more than ever, are committed to improving equity across communities and have taken great strides to help eliminate inequities. This session will examine the health equity initiatives in progress across the health care delivery system.
Expect a vibrant, professionally produced experience of a caliber only AHIP can deliver. The same level of expert-hosted content you expect from AHIP conferences, now in an interactive format that makes it easy to: